ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

CircCTNNA1 acts as a ceRNA for miR-363-3p to facilitate the progression of colorectal cancer by promoting CXCL5 expression

Zhang, Yan; Zheng, Sheng; Liao, Nansheng; Huang, Huifeng; Chen, Wenxiao; Wu, Zhenxing; Wu, Deqing*广东省人民医院
Journal of Biological Research-Thessaloniki2021-2-27DOI: 10.1186/s40709-021-00135-8
15被引10阅读
引用收藏
分享

摘要

Background Circular RNAs (circRNA) have been shown to be involved in the pathogenesis of colorectal cancer (CRC). CircCTNNA1 was found to be one of the upregulated circRNAs in CRC. However, there are few studies on circCTNNA1, so it is necessary to carry out further studies. Methods The expression of circCTNNA1, microRNA (miR)-363-3p, and chemokine C-X-C motif ligand 5 (CXCL5) was detected by quantitative real-time PCR (qRT-PCR). The protein levels of CXCL5 and metastasis markers were measured using western blot (WB) analysis. Cell proliferation, apoptosis, cell cycle, migration, and invasion were determined by cell counting kit 8 (CCK8) assay, colony formation assay, flow cytometry, and transwell assay. The relationship between miR-363-3p and circCTNNA1 or CXCL5 was evaluated via dual-luciferase reporter assay and RNA immunoprecipitation assay. Animal study was performed to explore the function of circCTNNA1 on CRC tumorigenesis. Results CircCTNNA1 and CXCL5 were highly expressed in CRC. Knockdown of circCTNNA1 could inhibit the proliferation, cell cycle, metastasis, and promote the apoptosis of CRC cells. MiR-363-3p could be sponged by circCTNNA1, and the inhibition effect of circCTNNA1 silencing on CRC progression could be reversed by miR-363-3p inhibitor. Moreover, miR-363-3p could interact with CXCL5, and CXCL5 overexpression also could reverse the suppressive effect of miR-363-3p on CRC progression. Downregulation of circCTNNA1 also could hinder the tumor growth of CRC in vivo. Conclusion CircCTNNA1 enhanced CRC progression via regulating the miR-363-3p/CXCL5 axis.

学科与关键词

关键词
Colorectal cancercircCTNNA1miR-363-3pCXCL5
相关
加载中…
  • Identification of the tumor-suppressive role of circular RNA-FOXO3 in colorectal cancer via regulation of miR-543/LATS1 axis
    Deng, Yun-Yao; Min, Yu-Juan; Zhou, Kun; Yang, Qing-Song; Peng, Mei; Cui, Zhao-Rui; Zhu, Xiang-Lian; Liu, Hao; Wang, Min; Zhang, Xie*; Liu, Li-Xin*Oncology Reports, 2021, 46(5): 239.被引 6
  • EIF4A3-induced circ_0084615 contributes to the progression of colorectal cancer via miR-599/ONECUT2 pathway
    Jiang, Zhipeng; Tai, Qinwen; Xie, Xiaojun; Hou, Zehui; Liu, Wei; Yu, Zhuomin; Liang, Zhiqiang; Chen, Shuang*JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2021, 40(1): 227.被引 25
  • Hsa_circ_0079557 Promotes the Proliferation of Colorectal Cancer Cells Through the hsa_circ_0079557/miR-502-5p/CCND1 Axis
    Yu, Chao; Huang, Xue; Huang, Renli; Wang, Peiqi; Cai, Zongda; Guo, Zeyi; Lan, Qingnan; Cao, Haodi; Yu, Jinlong*Cancer Genomics & Proteomics, 2023, 20(6): 567-581.
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Biological Research-Thessaloniki
发表日期
2021-02-27
卷期
第 28 卷, 第 1 期
页码
7
DOI
10.1186/s40709-021-00135-8
语言
ENGLISH
期刊收录
NSL
期刊等级
4区
成果收录
SCIE
资助标注
Yunnan Province high-level Health and Family planning Personnel Training Project (Yunwei Science and Education Development [2017]) [14]; Basic Research Joint Special General Project of Yunnan Provincial Local Universities (part) [2018FH001-076, 2018FH001-080]; Guangdong People's Hospital: College Subject [8197102513]

作者

  • Z

    Zhang, Yan (第一作者)

  • Z

    Zheng, Sheng

    third peoples hosp yunnan prov

查看全部 7 位作者收起作者
  • L

    Liao, Nansheng

  • H

    Huang, Huifeng

  • C

    Chen, Wenxiao

  • W

    Wu, Zhenxing

  • W

    Wu, Deqing (通讯)

    2 · guangdong prov peoples hosp

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417